Endocrine/Metabolic: Decreased libido, hypoglycemia, unstable diabetes, weight gain; Increases in the following: alkaline phosphatase, transaminases, lactate dehydrogenase, blood urea nitrogen (BUN), serum creatinine, uric acid.
Gastrointestinal: Abdominal pain, constipation, diarrhea, digestive tract disorders, dry mouth, flatulence, gastric pain, heartburn, hepatitis (rare), hiccups, jaundice (rare), nausea, non-specific hepatic dysfunction (rare), retroperitoneal fibrosis, vomiting, xerostomia.
Musculoskeletal: Arthritis, general weakness, muscle cramps, musculoskeletal pain, polymyalgia-like syndrome, restless legs.
Nervous: Confusion, decreased alertness, depression, dizziness, full headedness, hallucination, headache, impotence, increased dreaming, insomnia, lethargy, mental confusion, nervousness, nightmares, paresthesia, personality disorder, short-term memory loss, sleep disturbances, somnolence, tiredness, vertigo.
Respiratory: Bronchospasm, dyspnea, rhinitis, shortness of breath, wheezing.
Skin: Alopecia, dry skin, hyperhidrosis, photosensitivity (very rare), pruritus, rash, sweating, worsening of psoriasis (very rare).
Special senses: Blurred vision, dry eyes, eye irritation, hearing disorders (e.g., hypoacusis or deafness), tinnitus, visual disturbances.
Others: Peyronie's disease, agranulocytosis, fatigue, increased or decreased antinuclear factor (ANF) levels, lassitude, thrombocytopenia.
Potential Undesirable Effects: Cardiovascular: Intensification of AV block.
Hematologic: Eosinophilia, nonthrombocytopenic purpura, thrombocytopenic purpura.
Hypersensitivity reactions: Erythematous rash, fever combined with aching and sore throat, laryngospasm, respiratory distress.
Nervous: Reversible mental depression progressing to catatonia, acute reversible syndrome characterized by disorientation to time and place, emotional lability, slightly clouded sensorium, decreased performance on neuropyschometrics.
View ADR Reporting Link
Sign Out